The Supreme Court on Jan. 16, 2026, agreed to decide a case about how generic companies can communicate to the market about their products, ...
The US Supreme Court will hear generic drug maker Hikma Pharmaceuticals USA Inc.'s challenge of an appeals court holding that ...
A US Supreme Court fight over how branded drugs’ makers must plead induced infringement in “skinny-label” patent suits could ...
The Supreme Court of the US (SCOTUS) has agreed to hear a patent dispute between Amarin and Hikma that could have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results